Physician
S K Syal MD PA
S K Syal MD PA was paid $595K by Medicaid between Sep 2019 and Nov 2024, across 76 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 21% of everything it billed.
33Billing provider infoS K SYAL MD PA
TEXAS CITY, TX 77591
TEXAS CITY, TX 77591
33aNPI1669927851assigned 08/18/2016
33bProvider typePediatrics Physician
28Total paid$595K
24GClaims44,672
24DCodes billed76
24AFirst – last monthSep 2019 – Nov 2024
Compared with peers
Next to other Pediatrics Physician providers in Texas
Rank by total paid#470 of 1,136
Median peer was paid$329K
This provider vs. median1.8×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 114 | $3K | |
| 2020 | 1,761 | $8K | |
| 2021 | 7,152 | $48K | |
| 2022 | 14,792 | $211K | |
| 2023 | 13,168 | $217K | |
| 2024incomplete | 7,685 | $107K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 21% | 2,759 | 2,348 | $124K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 12% | 1,078 | 958 | $73K |
| 99000 | 8.6% | 5,356 | 2,200 | $51K | |
| 94010 | 6.3% | 1,847 | 1,637 | $37K | |
| 95012 | 6.2% | 1,932 | 1,650 | $37K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 4.6% | 369 | 316 | $27K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 4.5% | 3,587 | 1,599 | $27K |
| 92081 | 4.4% | 1,001 | 948 | $26K | |
| 90792 | Psychiatric diagnostic evaluation with medical services | 4.1% | 228 | 199 | $25K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 3.6% | 260 | 237 | $22K |
| 96112 | 3.1% | 218 | 202 | $18K | |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 2.8% | 449 | 388 | $17K |
64 more codes
| 36410 | 2.6% | 1,965 | $16K | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 2.6% | 221 | $16K |
| 96130 | 2.4% | 295 | $14K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 1.3% | 672 | $8K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 1.1% | 596 | $7K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 120 | $6K |
| 92552 | <1% | 872 | $5K | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 94 | $5K |
| 80061 | Lipid panel | <1% | 830 | $5K |
| 83655 | <1% | 809 | $5K | |
| 99417 | Prolong home eval add 15m | <1% | 536 | $4K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 850 | $4K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 520 | $4K |
| 99441 | <1% | 161 | $3K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 167 | $2K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 485 | $2K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 46 | $1K |
| 98960 | <1% | 2,350 | $1K | |
| 99354 | <1% | 19 | $1K | |
| 97802 | <1% | 858 | $810.07 | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 45 | $772.38 |
| 99383 | <1% | 26 | $732.12 | |
| 95076 | <1% | 48 | $499.00 | |
| 99382 | <1% | 17 | $369.88 | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 14 | $369.60 |
| 81002 | <1% | 154 | $276.77 | |
| 87807 | <1% | 32 | $156.81 | |
| 86580 | <1% | 36 | $147.42 | |
| 96160 | <1% | 2,343 | $146.49 | |
| 90461 | <1% | 129 | $114.38 | |
| 87430 | <1% | 13 | $108.12 | |
| 90688 | <1% | 49 | $90.12 | |
| 85014 | <1% | 57 | $67.05 | |
| 99078 | <1% | 25 | $42.78 | |
| 94760 | <1% | 917 | $12.81 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 16 | $10.33 |
| 96161 | <1% | 625 | $9.56 | |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | <1% | 964 | $0.44 |
| 90785 | 0% | 228 | $0.00 | |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 1,166 | $0.00 |
| G8539 | Functional outcome assessment documented as positive using a standardized tool and a care plan based on identified deficiencies is documented within two days of the functional outcome assessment | 0% | 371 | $0.00 |
| 3725F | 0% | 642 | $0.00 | |
| 90863 | 0% | 139 | $0.00 | |
| 99051 | 0% | 43 | $0.00 | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | 0% | 14 | $0.00 |
| 4551F | 0% | 149 | $0.00 | |
| 99173 | 0% | 50 | $0.00 | |
| 3078F | 0% | 14 | $0.00 | |
| 96158 | 0% | 39 | $0.00 | |
| 90734 | 0% | 12 | $0.00 | |
| 96127 | 0% | 2,040 | $0.00 | |
| 1111F | 0% | 1,138 | $0.00 | |
| 99402 | 0% | 181 | $0.00 | |
| 92283 | 0% | 812 | $0.00 | |
| 4060F | 0% | 110 | $0.00 | |
| A9150 | Non-prescription drugs | 0% | 88 | $0.00 |
| G8422 | Bmi not documented, documentation the patient is not eligible for bmi calculation | 0% | 14 | $0.00 |
| 3700F | 0% | 110 | $0.00 | |
| G8419 | Bmi documented outside normal parameters, no follow-up plan documented, no reason given | 0% | 41 | $0.00 |
| G8418 | Bmi is documented below normal parameters and a follow-up plan is documented | 0% | 50 | $0.00 |
| 0001F | 0% | 81 | $0.00 | |
| 85018 | 0% | 14 | $0.00 | |
| 96156 | 0% | 39 | $0.00 | |
| 3008F | 0% | 27 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSYAL, ASHU (OWNER)
| Provider | Location | Paid |
|---|---|---|
| Anupam MD PA | Pasadena, TX | $6.55M |
| Pediatric Medical Center, PA | Houston, TX | $2.71M |
| Gian S Bedi MD PA | Pasadena, TX | $2.47M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.